JP2021506858A5 - - Google Patents

Download PDF

Info

Publication number
JP2021506858A5
JP2021506858A5 JP2020533676A JP2020533676A JP2021506858A5 JP 2021506858 A5 JP2021506858 A5 JP 2021506858A5 JP 2020533676 A JP2020533676 A JP 2020533676A JP 2020533676 A JP2020533676 A JP 2020533676A JP 2021506858 A5 JP2021506858 A5 JP 2021506858A5
Authority
JP
Japan
Prior art keywords
pyridin
pyrrolo
triazolo
pyridine
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020533676A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021506858A (ja
JP7289301B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/065908 external-priority patent/WO2019125977A1/en
Publication of JP2021506858A publication Critical patent/JP2021506858A/ja
Publication of JP2021506858A5 publication Critical patent/JP2021506858A5/ja
Application granted granted Critical
Publication of JP7289301B2 publication Critical patent/JP7289301B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020533676A 2017-12-18 2018-12-17 4-アザインドール化合物 Active JP7289301B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762599875P 2017-12-18 2017-12-18
US62/599,875 2017-12-18
PCT/US2018/065908 WO2019125977A1 (en) 2017-12-18 2018-12-17 4-azaindole compounds

Publications (3)

Publication Number Publication Date
JP2021506858A JP2021506858A (ja) 2021-02-22
JP2021506858A5 true JP2021506858A5 (https=) 2022-01-06
JP7289301B2 JP7289301B2 (ja) 2023-06-09

Family

ID=65003548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020533676A Active JP7289301B2 (ja) 2017-12-18 2018-12-17 4-アザインドール化合物

Country Status (28)

Country Link
US (4) US10544143B2 (https=)
EP (1) EP3728252B1 (https=)
JP (1) JP7289301B2 (https=)
KR (1) KR102720550B1 (https=)
CN (1) CN111819176B (https=)
AR (1) AR113959A1 (https=)
AU (1) AU2018388464B2 (https=)
BR (1) BR112020011771A2 (https=)
CA (1) CA3085817A1 (https=)
CL (1) CL2020001546A1 (https=)
DK (1) DK3728252T3 (https=)
EA (1) EA202091484A1 (https=)
ES (1) ES2960411T3 (https=)
FI (1) FI3728252T3 (https=)
HR (1) HRP20231244T1 (https=)
HU (1) HUE064473T2 (https=)
IL (1) IL275344B2 (https=)
LT (1) LT3728252T (https=)
MX (1) MX2020006168A (https=)
PE (1) PE20210129A1 (https=)
PL (1) PL3728252T3 (https=)
PT (1) PT3728252T (https=)
RS (1) RS64728B1 (https=)
SG (1) SG11202005628RA (https=)
SI (1) SI3728252T1 (https=)
SM (1) SMT202300342T1 (https=)
TW (1) TWI689510B (https=)
WO (1) WO2019125977A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10071079B2 (en) 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
FI3728252T3 (fi) * 2017-12-18 2023-10-18 Bristol Myers Squibb Co 4-atsaindoliyhdisteitä
CA3085942A1 (en) * 2017-12-20 2019-06-27 Bristol-Myers Squibb Company Aryl and heteroaryl substituted indole compounds
BR112020011984A2 (pt) * 2017-12-20 2020-11-17 Bristol-Myers Squibb Company compostos de amino indol úteis como inibidores de tlr
US11299501B2 (en) * 2017-12-20 2022-04-12 Bristol-Myers Squibb Company Diazaindole compounds
JP7328977B2 (ja) 2018-02-12 2023-08-17 エフ. ホフマン-ラ ロシュ アーゲー ウイルス感染の処置および予防のための新規のスルホン化合物および誘導体
KR20210018818A (ko) 2018-06-05 2021-02-18 에프. 호프만-라 로슈 아게 자가면역 질환의 치료를 위한 테트라하이드로-1H-피라지노[2,1-a]이소인돌릴퀴놀린 화합물
EP3807270B1 (en) 2018-06-12 2023-09-13 F. Hoffmann-La Roche AG Novel heteroaryl heterocyclyl compounds for the treatment of autoimmune disease
US11952363B2 (en) 2018-07-23 2024-04-09 Hoffmann-La Roche Inc. Piperazine compounds for the treatment of autoimmune disease
WO2020048583A1 (en) 2018-09-04 2020-03-12 F. Hoffmann-La Roche Ag Benzothiazole compounds for the treatment of autoimmune diseases
WO2020048595A1 (en) 2018-09-06 2020-03-12 F. Hoffmann-La Roche Ag Novel cyclic amidine compounds for the treatment of autoimmune disease
JP7367004B2 (ja) 2018-09-06 2023-10-23 エフ. ホフマン-ラ ロシュ アーゲー 自己免疫疾患の処置のための新規のピラゾロビリジン化合物
WO2021067326A1 (en) * 2019-10-01 2021-04-08 Bristol-Myers Squibb Company Substituted bicyclic heteroaryl compounds
CN114829350B (zh) 2019-10-04 2024-05-28 百时美施贵宝公司 经取代的咔唑化合物
US12421240B2 (en) 2019-10-31 2025-09-23 Hoffmann-La Roche Inc. Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune disease
JP7652772B2 (ja) * 2019-11-01 2025-03-27 ブリストル-マイヤーズ スクイブ カンパニー 置換ピラゾール化合物
JP2023502087A (ja) 2019-11-19 2023-01-20 エフ.ホフマン-ラ ロシュ アーゲー 自己免疫疾患の処置のためのヒドロ-1H-ピロロ[1,2-a]ピラジン化合物
JP7649306B2 (ja) 2019-11-20 2025-03-19 エフ. ホフマン-ラ ロシュ アーゲー 自己免疫疾患の処置のためのスピロ(イソベンゾフラナゼチジン)化合物
AR123281A1 (es) * 2020-08-19 2022-11-16 Bristol Myers Squibb Co Compuestos bicíclicos sustituidos útiles como inhibidores de tlr9
AU2021328577A1 (en) * 2020-08-19 2023-03-23 Bristol-Myers Squibb Company 1H-pyrrolo[3,2-c]pyridine and 1H-pyrrolo[2,3-c]pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis
AR123286A1 (es) 2020-08-19 2022-11-16 Bristol Myers Squibb Co Compuestos de benzimidazol sustituidos útiles como inhibidores de tlr9
PE20231318A1 (es) * 2020-08-19 2023-08-24 Bristol Myers Squibb Co Compuestos heteroarilicos sustituidos utiles como inhibidores de tlr9
CN116490506B (zh) * 2020-11-26 2024-12-13 江苏恒瑞医药股份有限公司 稠合三环化合物、其制备方法及其在医药上的应用
CN116783202A (zh) * 2021-02-09 2023-09-19 吉利德科学公司 噻吩并吡咯化合物
KR20230171469A (ko) 2021-04-16 2023-12-20 길리애드 사이언시즈, 인코포레이티드 티에노피롤 화합물
EP4398989A1 (en) 2021-09-10 2024-07-17 Gilead Sciences, Inc. Thienopyrrole compounds
CN114591339B (zh) * 2022-05-10 2022-08-02 上海维申医药有限公司 一类Toll样受体抑制剂及其制备和应用
EP4688750A1 (en) 2023-04-06 2026-02-11 Pfizer Inc. Substituted indazole propionic acid derivative compounds and uses thereof as ampk activators

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9812944A (pt) 1997-10-20 2000-08-08 Hoffmann La Roche Inibidores bicìclicos da cinase
HUP0104987A3 (en) 1998-12-18 2002-09-30 Axys Pharmaceuticals Inc South Benzimidazole or indole derivatives protease inhibitors, and pharmaceutical compositions containing them
MXPA05013922A (es) 2003-06-20 2006-02-24 Coley Pharm Group Inc Antagonistas de receptor tipo toll de molecula pequena.
CA2564953A1 (en) 2004-05-03 2005-11-24 Janssen Pharmaceutica N.V. Novel indole derivatives as selective androgen receptor modulators (sarms)
WO2007115306A2 (en) 2006-04-04 2007-10-11 Myriad Genetics, Inc. Compounds for diseases and disorders
US20060235037A1 (en) 2005-04-15 2006-10-19 Purandare Ashok V Heterocyclic inhibitors of protein arginine methyl transferases
DE102006033109A1 (de) 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
US8027888B2 (en) 2006-08-31 2011-09-27 Experian Interactive Innovation Center, Llc Online credit card prescreen systems and methods
WO2008065198A1 (en) 2006-12-01 2008-06-05 Galapagos N.V. Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases
GB0708141D0 (en) 2007-04-26 2007-06-06 Syngenta Participations Ag Improvements in or relating to organic compounds
WO2008152471A1 (en) 2007-06-12 2008-12-18 Coley Pharmaceutical Group, Inc. Quinazoline derivative useful as toll-like receptor antagonist
WO2009030996A1 (en) 2007-09-05 2009-03-12 Coley Pharmaceutical Group, Inc. Triazole compounds as toll-like receptor (tlr) agonists
CL2009000904A1 (es) * 2008-04-21 2010-04-30 Shionogi & Co Compuestos derivados de ciclohexil sulfonamidas que tienen actividad antagonista en el receptor npy y5, composicion farmaceutica y formulacion farmaceutica que los comprende.
BRPI0915231A2 (pt) * 2008-07-08 2018-06-12 Intellikine Inc compostos inibidores de quinase e métodos de uso
US8354400B2 (en) 2008-09-26 2013-01-15 Eisai R&D Co., Ltd. Benzoxazole compounds and methods of use
CA2738929A1 (en) * 2008-10-17 2010-04-22 Boehringer Ingelheim International Gmbh Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
RS53347B (sr) * 2008-12-09 2014-10-31 Gilead Sciences, Inc. Modulatori toll-sličnih receptora
TWI462920B (zh) 2009-06-26 2014-12-01 葛萊伯格有限公司 用於治療退化性及發炎疾病之新穎化合物
NO2453895T3 (https=) 2009-07-16 2018-10-20
WO2012054862A2 (en) 2010-10-21 2012-04-26 The Brigham And Women's Hospital, Inc. Agents, compositions, and methods for treating pruritis and related skin conditions
EP3208263A1 (en) 2011-01-12 2017-08-23 VentiRx Pharmaceuticals, Inc. Substituted benzoazepines as toll-like receptor modulators
DK2663555T3 (en) 2011-01-12 2017-03-27 Ventirx Pharmaceuticals Inc SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
CA2837227C (en) 2011-06-01 2022-05-10 Janus Biotherapeutics, Inc. Novel immune system modulators
WO2012167053A1 (en) 2011-06-01 2012-12-06 Janus Biotherapeutics, Inc. Novel immune system modulators
CA2836487A1 (en) 2011-06-09 2012-12-13 Rhizen Pharmaceuticals Sa Novel compounds as modulators of gpr-119
TWI567079B (zh) 2011-07-15 2017-01-21 健生醫藥公司 作為伽瑪分泌酶調節劑之新穎的經取代的吲哚衍生物
JP2013075834A (ja) * 2011-09-29 2013-04-25 Kowa Co Tlr9阻害活性を有するピラゾロピリミジン−7−アミン誘導体
CA2850932A1 (en) 2011-10-04 2013-04-11 Janus Biotherapeutics, Inc. Novel imidazole quinoline-based immune system modulators
JP6184423B2 (ja) 2012-05-18 2017-08-23 大日本住友製薬株式会社 カルボン酸化合物
JO3407B1 (ar) * 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
EP2738172A1 (en) * 2012-11-28 2014-06-04 Almirall, S.A. New bicyclic compounds as crac channel modulators
SG10202103278TA (en) 2013-10-14 2021-04-29 Eisai R&D Man Co Ltd Selectively substituted quinoline compounds
EP3080124A1 (en) 2013-12-13 2016-10-19 Takeda Pharmaceutical Company Limited Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors
HRP20210927T1 (hr) 2014-08-15 2021-09-03 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Spojevi pirolopirimidina koje se koriste kao agonist tlr7
EP3183251A4 (en) 2014-08-22 2017-12-27 Janus Biotherapeutics, Inc. Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
AR103232A1 (es) * 2014-12-22 2017-04-26 Bristol Myers Squibb Co ANTAGONISTAS DE TGFbR
MX391344B (es) 2016-07-30 2025-03-21 Bristol Myers Squibb Co Compuestos indol sustituidos con dimetoxifenilo como inhibidores de receptores tipo toll 7, 8 o 9 (tlr7, tlr8 o tlr9).
KR102519535B1 (ko) 2016-09-09 2023-04-06 브리스톨-마이어스 스큅 컴퍼니 피리딜 치환된 인돌 화합물
FI3728252T3 (fi) * 2017-12-18 2023-10-18 Bristol Myers Squibb Co 4-atsaindoliyhdisteitä

Similar Documents

Publication Publication Date Title
JP2021506858A5 (https=)
IL275344B2 (en) 4-azaindole compounds
JP2021506923A5 (https=)
US11427580B2 (en) 6-azaindole compounds
JP2021507912A5 (https=)
US10544150B2 (en) NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders
JP5690823B2 (ja) Jak受容体およびタンパク質チロシンキナーゼ阻害薬としての複素環化合物
JP2021506941A5 (https=)
AU2023201522B2 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
JP2019535664A5 (https=)
KR101812357B1 (ko) Cdk4/6의 억제제로서의 피롤로피리미딘 화합물
JP2021506816A5 (https=)
JP2021506889A5 (https=)
US20210087174A1 (en) Aryl and heteroaryl substituted indole compounds
AU2018373258B2 (en) Substituted furanopyrimidine compounds as PDE1 inhibitors
JP2014506929A5 (https=)
KR20180083323A (ko) N-설포닐화 피라졸로[3,4-b]피리딘-6-카복스아미드 및 사용 방법
JP2018500376A5 (https=)
JP2012519678A5 (https=)
US20200399268A1 (en) Pharmaceutical 6,5 Heterobicyclic Ring Derivatives
JP2016525092A5 (https=)
HRP20210285T1 (hr) Derivati ((piridin-2-il)-amino)pirido[3,4-d]pirimidina i ((piridazin-3-il)-amino)pirido[3,4-d]pirimidina kao inhibitori cdk4/6 za liječenje npr. reumatoidnog artritisa, arterioskleroze, plućne fibroze, cerebralnog infarkta ili raka
JP2019502680A5 (https=)
CN121285552A (zh) 作为ddr抑制剂的杂芳基衍生物
US20260035387A1 (en) Compounds for treating huntington's disease